Match!

Vascular Cognitive Impairment Neuropathology Guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment

Published on Nov 1, 2016in Brain11.814
· DOI :10.1093/brain/aww214
Olivia Skrobot7
Estimated H-index: 7
(UoB: University of Bristol),
Johannes Attems46
Estimated H-index: 46
(Newcastle University)
+ 10 AuthorsSeth Love61
Estimated H-index: 61
(UoB: University of Bristol)
Sources
Abstract
There are no generally accepted protocols for post-mortem assessment in cases of suspected vascular cognitive impairment. Neuropathologists from seven UK centres have collaborated in the development of a set of vascular cognitive impairment neuropathology guidelines (VCING), representing a validated consensus approach to the post-mortem assessment and scoring of cerebrovascular disease in relation to vascular cognitive impairment. The development had three stages: (i) agreement on a sampling protocol and scoring criteria, through a series of Delphi method surveys; (ii) determination of inter-rater reliability for each type of pathology in each region sampled (Gwet’s AC2 coefficient); and (iii) empirical testing and validation of the criteria, by blinded post-mortem assessment of brain tissue from 113 individuals (55 to 100 years) without significant neurodegenerative disease who had had formal cognitive assessments within 12 months of death. Fourteen different vessel and parenchymal pathologies were assessed in 13 brain regions. Almost perfect agreement (AC2 > 0.8) was found when the agreed criteria were used for assessment of leptomeningeal, cortical and capillary cerebral amyloid angiopathy, large infarcts, lacunar infarcts, microhaemorrhage, larger haemorrhage, fibrinoid necrosis, microaneurysms, perivascular space dilation, perivascular haemosiderin leakage, and myelin loss. There was more variability (but still reasonably good agreement) in assessment of the severity of arteriolosclerosis (0.45–0.91) and microinfarcts (0.52–0.84). Regression analyses were undertaken to identify the best predictors of cognitive impairment. Seven pathologies—leptomeningeal cerebral amyloid angiopathy, large infarcts, lacunar infarcts, microinfarcts, arteriolosclerosis, perivascular space dilation and myelin loss—predicted cognitive impairment. Multivariable logistic regression determined the best predictive models of cognitive impairment. The preferred model included moderate/severe occipital leptomeningeal cerebral amyloid angiopathy, moderate/severe arteriolosclerosis in occipital white matter, and at least one large infarct (area under the receiver operating characteristic curve 77%). The presence of 0, 1, 2 or 3 of these features resulted in predicted probabilities of vascular cognitive impairment of 16%, 43%, 73% or 95%, respectively. We have developed VCING criteria that are reproducible and clinically predictive. Assuming our model can be validated in an independent dataset, we believe that this will be helpful for neuropathologists in reporting a low, intermediate or high likelihood that cerebrovascular disease contributed to cognitive impairment. * Abbreviations : CAA : cerebral amyloid angiopathy MMSE : Mini-Mental State Examination ROC : receiver operating characteristic VCI : vascular cognitive impairment VCING : vascular cognitive impairment neuropathology guidelines
Figures & Tables
  • References (68)
  • Citations (53)
📖 Papers frequently viewed together
882 Citations
95 Citations
20116.05Stroke
1,016 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References68
Newest
#1Eseosa T. Ighodaro (UK: University of Kentucky)H-Index: 10
#2Erin L. Abner (UK: University of Kentucky)H-Index: 36
Last. Peter T. Nelson (UK: University of Kentucky)H-Index: 60
view all 16 authors...
Risk factors and cognitive sequelae of brain arteriolosclerosis pathology are not fully understood. To address this, we used multimodal data from the National Alzheimer's Coordinating Center and Alzheimer's Disease Neuroimaging Initiative data sets. Previous studies showed evidence of distinct neurodegenerative disease outcomes and clinical-pathological correlations in the “oldest-old” compared to younger cohorts. Therefore, using the National Alzheimer's Coordinating Center data set, we analyze...
31 CitationsSource
#1J. Scott Miners (UoB: University of Bristol)H-Index: 16
#2Jennifer C Palmer (UoB: University of Bristol)H-Index: 12
Last. Seth Love (UoB: University of Bristol)H-Index: 61
view all 3 authors...
The earliest decline in cerebral perfusion in Alzheimer's disease (AD) is in the medial parietal cortex (precuneus). We have analyzed precuneus in post-mortem tissue from 70 AD and 37 control brains to explore the pathophysiology of the hypoperfusion: the contribution of arteriolosclerotic small vessel disease (SVD) and cerebral amyloid angiopathy (CAA), and of the vasoconstrictors endothelin-1 (EDN1) and angiotensin II (Ang II), and the association with Aβ. The myelin-associated glycoprotein:pr...
33 CitationsSource
#1Seth Love (UoB: University of Bristol)H-Index: 61
#2J. Scott Miners (UoB: University of Bristol)H-Index: 16
Cerebrovascular disease (CVD) and Alzheimer’s disease (AD) have more in common than their association with ageing. They share risk factors and overlap neuropathologically. Most patients with AD have Aβ amyloid angiopathy and degenerative changes affecting capillaries, and many have ischaemic parenchymal abnormalities. Structural vascular disease contributes to the ischaemic abnormalities in some patients with AD. However, the stereotyped progression of hypoperfusion in this disease, affecting fi...
67 CitationsSource
#1Emma L. Ashby (UoB: University of Bristol)H-Index: 9
#2James Scott Miners (UoB: University of Bristol)H-Index: 13
Last. Seth Love (UoB: University of Bristol)H-Index: 61
view all 4 authors...
Epidemiological data associate hypertension with a predisposition to Alzheimer's disease (AD), and a number of postmortem and in vivo studies also demonstrate that hypertension increases amyloid- (A) pathology. In contrast, anti- hypertensive medications reportedly improve cognition and decrease the risk of AD, while certain classes of anti-hypertensive drugs are associated with decreased AD-related pathology. We investigated the effects of hypertension and anti-hypertensive treatment on A plaqu...
16 CitationsSource
#1Giuseppe Tosto (Columbia University)H-Index: 15
#2Molly E. Zimmerman (Albert Einstein College of Medicine)H-Index: 35
Last. Adam M. Brickman (Columbia University)H-Index: 58
view all 5 authors...
Abstract Introduction It is unclear whether white matter hyperintensities (WMHs), magnetic resonance imaging markers of small-vessel cerebrovascular disease, promote neurodegeneration and associated clinical decline in Alzheimer's disease (AD), or simply co-occur with recognized pathogenic processes. Methods In 169 patients with mild cognitive impairment, followed for 3 years, we examined the association of (1) baseline regional WMH and cerebral spinal fluid–derived t-tau (total tau) with entorh...
33 CitationsSource
#1Kirsty E. McAleese (Newcastle University)H-Index: 7
#2Michael J. Firbank (Newcastle University)H-Index: 48
Last. Johannes Attems (Newcastle University)H-Index: 46
view all 11 authors...
Introduction Cerebral white matter lesions (WML), visualized as white matter hyperintensities (WMH) on T2-weighted MRI, encompass structural damage and loss of integrity of the cerebral white matter (WM) and are commonly assumed to be associated with small vessel disease (SVD). However, it has been suggested that WM damage may also be the result of degenerative axonal loss that is secondary to cortical Alzheimer’s disease (AD) pathologies i.e., hyperphosphorylated tau (HPτ) and amyloid-beta (Aβ)...
26 CitationsSource
#1Tl Thomas (UoB: University of Bristol)H-Index: 4
#2Scott Miners (UoB: University of Bristol)H-Index: 5
Last. Seth Love (UoB: University of Bristol)H-Index: 61
view all 3 authors...
Perfusion is reduced in the cerebral neocortex in Alzheimer’s disease. We have explored some of the mechanisms, by measurement of perfusion-sensitive and disease-related proteins in post-mortem tissue from Alzheimer’s disease, vascular dementia and age-matched control brains. To distinguish physiological from pathological reduction in perfusion (i.e. reduction exceeding the decline in metabolic demand), we measured the concentration of vascular endothelial growth factor (VEGF), a protein induced...
65 CitationsSource
#1Seth Love (UoB: University of Bristol)H-Index: 61
#2J. Scott Miners (UoB: University of Bristol)H-Index: 16
Neuroimaging has revealed a range of white matter abnormalities that are common in dementia, some that predict cognitive decline. The abnormalities may result from structural diseases of the cerebral vasculature, such as arteriolosclerosis and amyloid angiopathy, but can also be caused by nonstructural vascular abnormalities (eg, of vascular contractility or permeability), neurovascular instability or extracranial cardiac or vascular disease. Conventional histopathological assessment of the whit...
23 CitationsSource
#1Scott Miners (UoB: University of Bristol)H-Index: 5
#2H. A. Moulding (UoB: University of Bristol)
Last. Seth Love (UoB: University of Bristol)H-Index: 61
view all 4 authors...
In dementia with Lewy bodies (DLB), blood flow tends to be reduced in the occipital cortex. We previously showed elevated activity of the endothelin and angiotensin pathways in Alzheimer's disease (AD). We have measured endothelin-1 (ET-1) level and angiotensin-converting enzyme (ACE) activity in the occipital cortex in DLB and control brains. We also measured vascular endothelial growth factor (VEGF); factor VIII-related antigen (FVIIIRA) to indicate microvessel density; myelin-associated glyco...
28 CitationsSource
#1Rachel Barker (UoB: University of Bristol)H-Index: 7
#2Emma L. Ashby (UoB: University of Bristol)H-Index: 9
Last. Seth Love (UoB: University of Bristol)H-Index: 61
view all 8 authors...
Little is known about the contributors and physiological responses to white matter hypoperfusion in the human brain. We previously showed the ratio of myelin-associated glycoprotein to proteolipid protein 1 in post-mortem human brain tissue correlates with the degree of ante-mortem ischaemia. In age-matched post-mortem cohorts of Alzheimer’s disease (n = 49), vascular dementia (n = 17) and control brains (n = 33) from the South West Dementia Brain Bank (Bristol), we have now examined the relatio...
57 CitationsSource
Cited By53
Newest
#1Yasuo Miki (Hirosaki University)H-Index: 13
#2Sandrine C. FotiH-Index: 3
Last. Niall QuinnH-Index: 101
view all 12 authors...
Recent post-mortem studies reported 22-37% of patients with multiple system atrophy can develop cognitive impairment. With the aim of identifying associations between cognitive impairment including memory impairment and alpha-synuclein pathology, 148 consecutive patients with pathologically proven multiple system atrophy were reviewed. Among them, 118 (79.7%) were reported to have had normal cognition in life, whereas the remaining 30 (20.3%) developed cognitive impairment. Twelve of them had pu...
Source
#1Luisa VinciguerraH-Index: 6
#2Giuseppe Lanza (University of Catania)H-Index: 23
Last. Mariagiovanna CantoneH-Index: 18
view all 7 authors...
In the last years, there has been a significant growth in the literature exploring the pathophysiology of vascular cognitive impairment (VCI). As an “umbrella term” encompassing any degree of vascular-related cognitive decline, VCI is deemed to be the most common cognitive disorder in the elderly, with a significant impact on social and healthcare expenses. Interestingly, some of the molecular, biochemical, and electrophysiological abnormalities detected in VCI seem to correlate with disease pro...
Source
AIMS: Most individuals with AD neuropathological changes have co-morbidities which have an impact on the integrity of the WM. The present study analyses oligodendrocyte and myelin markers in the frontal WM in a series of AD cases without clinical or pathological co-morbidities. METHODS: From a consecutive autopsy series, 206 cases had neuropathological changes of AD; among them, only 33 were AD without co-morbidities. WM alterations were first evaluated in coronal sections of the frontal lobe in...
Source
#1Hui Lu (Southern Medical University)H-Index: 1
#2Junying Zhang (McGovern Institute for Brain Research)H-Index: 12
Last. He Li (McGovern Institute for Brain Research)H-Index: 1
view all 12 authors...
Abstract With the increasing incidence of cerebrovascular diseases and dementia, considerable efforts have been made to develop effective treatments on vascular cognitive impairment (VCI), among which accumulating practice-based evidence has shown great potential of the traditional Chinese medicine (TCM). Current randomized double-blind controlled trial has been designed to evaluate the 6-month treatment effects of Dengzhan Shengmai (DZSM) capsules, one TCM herbal preparations on VCI, and to exp...
1 CitationsSource
#1Dejan Jakimovski (SUNY: State University of New York System)H-Index: 6
#2Ralph H. B. Benedict (SUNY: State University of New York System)H-Index: 59
Last. Robert Zivadinov (SUNY: State University of New York System)H-Index: 64
view all 7 authors...
Background:The cognitive performance in multiple sclerosis (MS) patients declines with aging, longer disease duration, and possibly cardiovascular comorbidities.Objectives:We investigated whether l...
4 CitationsSource
#1Franc Llorens (GAU: University of Göttingen)H-Index: 23
#2Peter Hermann (GAU: University of Göttingen)H-Index: 8
Last. Daniela Varges (GAU: University of Göttingen)H-Index: 17
view all 18 authors...
The clinical diagnosis of vascular dementia (VaD) is based on imaging criteria, and specific biochemical markers are not available. Here, we investigated the potential of cerebrospinal fluid (CSF) lipocalin 2 (LCN2), a secreted glycoprotein that has been suggested as mediating neuronal damage in vascular brain injuries. The study included four independent cohorts with a total n = 472 samples. LCN2 was significantly elevated in VaD compared to controls, Alzheimer’s disease (AD), other neurodegene...
Source
#1Andrew Robinson (University of Manchester)H-Index: 25
#2Stephen Chew-Graham (University of Manchester)H-Index: 2
Last. David M. A. Mann (University of Manchester)H-Index: 87
view all 11 authors...
In the present study, we have characterized and compared individuals whose brains were donated as part of The University of Manchester Longitudinal Study of Cognition in Normal Healthy Old Age (UoM) with those donated through the Manchester arm of the UK Brains for Dementia Research (BDR) program. The aim of this study was to investigate how differences in study recruitment may affect final pathological composition of cohort studies. The UoM cohort was established as a longitudinal study of agin...
Source
#1Viviana Frantellizzi (Sapienza University of Rome)H-Index: 4
#2Arianna Pani (University of Milan)H-Index: 1
Last. Giuseppe De Vincentis (Sapienza University of Rome)H-Index: 21
view all 6 authors...
Cerebrovascular diseases are well established causes of cognitive impairment. Different etiologic entities, such as vascular dementia (VaD), vascular cognitive impairment, subcortical (ischemic) VaD, and vascular cognitive disorder, are included in the umbrella definition of vascular cognitive impairment and dementia (VCID). Because of the variability of VCID clinical presentation, there is no agreement on criteria defining the neuropathological threshold of this disorder. In fact, VCID is chara...
Source
#1Yoshiki Hase (Newcastle University)H-Index: 5
#2Tuomo Polvikoski (Newcastle University)H-Index: 28
Last. Raj N. Kalaria (Newcastle University)H-Index: 39
view all 16 authors...
Autonomic dysfunction may affect brain blood flow and result in intermittent cerebral hypoperfusion, which is recognised as a cause of cognitive impairment and dementia. We assessed the burden of small vessel disease pathology in elderly subjects who had clinical evidence of autonomic dysfunction and had developed neurodegenerative dementias or vascular dementia (VaD). Clinical and neuropathological diagnosis in 118 subjects comprised dementia with Lewy bodies (DLB), Parkinson’s disease with dem...
1 CitationsSource
#1Pedram Honarpisheh (University of Texas at Austin)
#2Louise D. McCullough (University of Texas at Austin)H-Index: 55
Source